Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases

BACKGROUND: Interferon-β (IFN-β) is an effective drug in multiple sclerosis (MS) but it may cause acute exacerbation of MS following the initiation of treatment. This study evaluated patients with rapid exacerbation of multiple sclerosis (REMS) following the initiation of IFN-β. METHODS: We retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Etemadifar, Masoud, Sarrami, Amir Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434905/
https://www.ncbi.nlm.nih.gov/pubmed/22973372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434905/
https://www.ncbi.nlm.nih.gov/pubmed/22973372

Ejemplares similares